Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Hair Growth Supplement and Treatment Market

Hair Growth Supplement and Treatment Market Trends

Report ID: GMI9725
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Hair Growth Supplement and Treatment Market Trends

The increasing prevalence of hair disorders significantly drives the market.

For instance, as per an article published by UnitedCare in May 2024, it has been reported that an average person a day loses about 100 hair stands per day. In current statistics, by the age of 30, 25% men and 12% women lose hair. In addition, 95% of hair loss in men is caused by androgenetic alopecia or common male pattern baldness. Thus, with the rise in the adoption of unhealthy diets, stress and pollution hair loss become more and more common. Therefore, the high prevalence of hair loss necessitates an increasing product demand, thereby driving market growth.
Moreover, there is a rising trend towards natural and organic hair care products. Nowadays, consumers are increasingly looking for supplements and treatments that contain natural ingredients and are free from harmful chemicals. This demand stimulates research and development in hair supplements manufacturing, leading to the introduction of advanced therapies that further drive market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Hair growth supplement and treatment market size was USD 7.8 billion in 2023 and is expected to register 6.1% CAGR from 2024-2032 owing to the increasing prevalence of hair disorders such as alopecia areata, telogen effluvium, and other scalp conditions worldwide.

The pharmaceuticals segment reached USD 5.6 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to increasing incidence of hair loss conditions such as androgenetic alopecia and alopecia areata.

North America hair growth supplement and treatment industry held 44.5% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to companies investing heavily in research and development and distribution in the region.

Amway Corporation, GNC Holdings, Inc., HUM Nutrition, Nature